Leifeng network news, on December 29, medical imaging AI company Shukun Technology signed a strategic cooperation agreement with the domestic health examination leader Meinian Health Group in Beijing, and the two sides will carry out in-depth cooperation around early screening and health management of chronic diseases.
Digital Kun Technology will apply its "Health Digital Doctor" products to intelligently upgrade the health examination and medical institutions under Meinian Health Group throughout the country.
Mao Xinsheng, chairman of Shukun Technology, said that intelligent health management is "AI + health management", that is, the digital doctors and digital human bodies of Shukun Technology are applied to the medical and health field, from the hospital end to the physical examination end, from the treatment link to the prevention and intervention link, so that health management is more intelligent and humane. The goal and vision of Digital Kun intelligent health management is: from the early diagnosis and early treatment of health examination and medical services, to provide human beings with the protection and care of the whole life cycle, in the future, everyone will have a digital human body, real-time recording of human health changes, and escorted by digital doctors for their health.
Yu Rong, chairman of Meinian Health Group, said that in recent years, Meinian Health has adhered to digital transformation, and through advanced technical means such as big data and artificial intelligence, it has pioneered and innovated in precision medicine, cancer screening, genetic testing, etc., empowering the whole process of pre-examination, during and post-examination, and continuously improving diagnostic capabilities. In the future, Meinian Health will work with Shukun Technology to further increase the layout and application of artificial intelligence innovative technologies, generate more value through technology empowerment, build a solid foundation for effective screening of diseases, and make more contributions to the implementation of the Healthy China Strategy in the field of preventive medicine.
According to Leifeng Network, projects such as the "heart-lung screening" of Shukun Technology have been carried out in the physical examination institutions under Meinian Health Group.
At present, the "Digital Doctor" product portfolio of Shukun Technology includes 12 products and 25 candidate products, and the original research and development of "Digital Heart", "Digital Brain" and "Digital Liver" are the world's first artificial intelligence solutions. "Digital doctor" products have been used daily in more than 1,600 hospitals across the country with high viscosity, with a cumulative service of more than 100 million person-times, and increasing at a rate of 10% per month, of which the coverage rate of top three hospitals has reached 40%.
In addition, Shukun Technology has obtained 2 State Drug Administration (NMPA) Class III medical device registration certificates, 11 NMPA Class II medical device registration certificates and 4 MDR CE certifications.
Meinian Health is the largest non-public physical examination leading enterprise in China, including "Meinian Great Health", "Ciming", "Aoya", "Meizhao" four brands, the company has laid out 607 physical examination centers in more than 300 cities across the country, and the number of physical examinations has reached nearly 30 million person-times per year.
In July this year, the National Health Commission issued a notice on accelerating the mutual recognition of inspection and inspection results, requiring all localities to do a good job in publicizing mutual recognition institutions and projects. Meinian Health's subsidiaries in Shanghai, Hangzhou, Wuhan and other places have signed contracts with the top three hospitals to build a medical association, participated in the work of the local health administrative department on the mutual recognition of test results, and have been included in the local mutual recognition system.
At present, the commercialization logic of medical imaging artificial intelligence has been publicly recognized by the core demand side.
According to the forecast of the third-party CCT report, the global artificial intelligence medical imaging solutions market is expected to grow exponentially from less than $1 billion in 2020 to $64.6 billion by 2025, with a compound growth rate of 147.7%. It is expected to reach a further US$166.5 billion (about 1 trillion yuan) in 2030, and the market capacity will expand nearly 170 times in 10 years. The size of the Chinese intelligent medical imaging market is expected to reach a scale of 155.4 billion yuan in 2030, of which the compound annual growth rate of the market by 2025 is expected to reach 135.9%, and the overall market size is about to grow to 44.2 billion yuan in 2025.
According to the report, the entire Chinese intelligent medical imaging market can be divided into three major blocks, in addition to the diagnosis and treatment mainly based on the hospital scene and the two major markets, the health management in the out-of-hospital scene will also be an important component of the overall market, and it is expected that the health management market will reach a scale of 32.2 billion yuan by 2030, accounting for 20% of the overall market share of AI medical imaging.
According to iiMedia Research, it is expected that by 2025, China's health examination market will exceed 300 billion yuan, and disease prevention as the core issue of the policy will promote the continuous innovation and expansion of the health examination industry. Industry insiders pointed out that the continuous introduction of policies at the national level to emphasize the importance of prevention is a positive signal for the health prevention industry and has entered a policy dividend period.
At present, Shukun Technology has taken the lead in the commercialization of diagnosis and treatment in hospitals, and the health management market will also be an important direction of force, and a variety of payment methods will become an important way for medical AI companies to achieve sustainable profitability.
![Take stock of the new look of a better life in 2021: more than 100 new life forces to release economic potential[fig]](data:image/gif;base64,R0lGODlhAQABAIAAAP///wAAACwAAAAAAQABAAACAkQBADs=)